249 related articles for article (PubMed ID: 26026251)
1. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution.
Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI
Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
Ahirrao M; Shrotriya S
Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured cubosomes in an
Patil RP; Pawara DD; Gudewar CS; Tekade AR
J Liposome Res; 2019 Sep; 29(3):264-273. PubMed ID: 30501444
[TBL] [Abstract][Full Text] [Related]
4. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
[TBL] [Abstract][Full Text] [Related]
5. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone.
Abdelrahman FE; Elsayed I; Gad MK; Elshafeey AH; Mohamed MI
Int J Pharm; 2017 Sep; 530(1-2):1-11. PubMed ID: 28733244
[TBL] [Abstract][Full Text] [Related]
6. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
8. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies.
Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM
AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921
[TBL] [Abstract][Full Text] [Related]
9. Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization.
El-Dahmy RM; Elsayed I; Elshafeey AH; Gawad NA; El-Gazayerly ON
Int J Pharm; 2014 Dec; 477(1-2):39-46. PubMed ID: 25290813
[TBL] [Abstract][Full Text] [Related]
10. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
11. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
Sharma S; Lohan S; Murthy RS
Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
[TBL] [Abstract][Full Text] [Related]
12. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation.
Hosny KM
Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940
[TBL] [Abstract][Full Text] [Related]
13. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of Brain Bioavailability Using Thermoreversible Cubosomal Formulation.
Jain H; Prabhakar B; Shende PK
Mol Pharm; 2024 May; 21(5):2534-2543. PubMed ID: 38547474
[TBL] [Abstract][Full Text] [Related]
15. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
[TBL] [Abstract][Full Text] [Related]
16. Intranasal spray of cubosomal tizanidine hydrochloride for brain targeting:
Thakkar H; Modi B; Patel B
J Microencapsul; 2023 Dec; 40(5):366-383. PubMed ID: 37129532
[TBL] [Abstract][Full Text] [Related]
17. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Shelke S; Shahi S; Jalalpure S; Dhamecha D
J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal
Patil R; Patil AS; Chougule K; Gaude Y; Masareddy RS
Drug Dev Ind Pharm; 2024 Jan; 50(1):68-77. PubMed ID: 38148515
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients.
El-Enin HA; Al-Shanbari AH
Saudi Pharm J; 2018 Sep; 26(6):790-800. PubMed ID: 30202219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
